top of page

Breast cancer: New research, new drug, new hope

In February of this year, the Food and Drug Administration approved a new targeted therapy for hard-to-treat advanced breast cancers. Its development was made possible by research and advocacy from the lab of Donald McDonnell, PhD, of Glaxo Wellcome.

Want to read more?

Subscribe to to keep reading this exclusive post.



Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page